NVAX — Novavax Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapTurnaround

Annual balance sheet for Novavax, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,515	1,337	569	923	735
Net Total Accounts Receivable
Net Total Receivables	455	82.4	297	108	106
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,155	1,703	1,144	1,129	978
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	269	400	491	300	67.7
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	2,577	2,259	1,797	1,560	1,177
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,390	2,460	1,635	1,154	460
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2,928	2,893	2,514	2,184	1,304
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-352	-634	-717	-624	-128
Total Liabilities & Shareholders' Equity	2,577	2,259	1,797	1,560	1,177
Total Common Shares Outstanding